Brief: Castle Biosciences - Decisiondx-SCC Clinical Utility Study Published In Cancer Investigation

Castle Biosciences

31/10/2022 11:31

Oct 31 (Reuters) - Castle Biosciences Inc  CSTL.O :
    * REAL-WORLD CLINICAL UTILITY STUDY PUBLISHED IN CANCER
INVESTIGATION DEMONSTRATES THE IMPACT OF DECISIONDX®-SCC TEST
RESULTS IN GUIDING RISK-ALIGNED CARE FOR PATIENTS WITH CUTANEOUS
SQUAMOUS CELL CARCINOMA

Source text for Eikon:  ID:nBwbvgW5Ya 
Further company coverage:  CSTL.O 
 ((Reuters.Briefs@thomsonreuters.com;))